An ‘exercise hormone’ has been reported to mediate the benefit of exercise in Alzheimer’s disease models by enhancing synaptic plasticity and memory.
Browsing: Cognitive/neurodegenerative disorders
A recent study has implicated that sticky proteins associated with neurodegenerative diseases could be transferred in mouse models.
A recent study has indicated that problem-solving activities do not protect against mental decline but instead, imparts a higher starting point from which decline is observed.
Three novel radiopharmaceuticals have been evaluated for their potential to be utilized in PET imaging of tau proteins in humans. The results of the study have the potential to improve the way we diagnose and treat Alzheimer’s disease.
Research demonstrates that female mice display a unique pattern of fluctuation in sex hormones during the ovarian cycle that could be linked to cognitive impairments such as Alzheimer’s disease.
Aoife Kiely, from our partner Alzheimer’s Society (London, UK), provides us with an overview on Brains for Dementia Research.
Researchers have demonstrated that a DNA vaccine tested in mice is effective at reducing accumulation of tau and beta-amyloid proteins associated with Alzheimer’s disease.
Research presented at SfN has provided insight into the neural risks and benefits of marijuana use, including development and Alzheimer’s disease.
Five studies presented at SfN collectively delve into why a healthy heart and lungs may guard against Alzheimer’s disease and vascular dementia.
New studies reveal that exosomes transported between cells produce a wide-range of effects neurologically and throughout the body, from passing the effects of trauma onto the next generation to helping neurons communicate.